Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda save search
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
Published: 2021-11-24 (Crawled : 12:00) - globenewswire.com
AGNPF | $0.089 24.3% 178.69% 0
|
Health Technology
|
| O: 14515.38%
H: 0.0%
C: -1.95%
fda lung cancer phase 1 positive cancer phase 2
Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
RMTI | $1.53 0.99% 0.98% 32K
|
Health Technology
|
| O: 1157.14%
H: 2.03%
C: -32.56%
fda application trial home phase 2
Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution
Published: 2023-09-25 (Crawled : 21:00) - globenewswire.com
FEMY | $1.33 4.72% 5.22% 280
|
Manufacturing
|
| O: 267.91%
H: 36.07%
C: 21.31%
fda solution treatment clearance market
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
BCDA P | $0.376 2.23% -2.56% 83
|
Health Technology
|
| O: 223.31%
H: 20.16%
C: -17.05%
fda approval cell cardiamp heart therapy
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $2.65 0.38% -1.12% 35K
|
Health Technology
|
| O: 171.75%
H: 308.97%
C: 243.67%
fda device treatment clearance therapeutics
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
Published: 2021-06-14 (Crawled : 12:00) - biospace.com/
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 169.39%
H: 9.34%
C: -42.85%
fda fda acceptance potential hiv bioscience
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®
Published: 2021-03-15 (Crawled : 11:00) - ir.check-cap.com
CHEK | $2.29 1.33% -0.89% 15K
|
Health Technology
|
| O: 164.71%
H: 10.86%
C: -24.2%
fda approval fda ide
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-09-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 43K
|
Health Technology
|
| O: 155.13%
H: 48.78%
C: -35.98%
positive fda sulopenem treatment injection infections
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034
Published: 2023-11-27 (Crawled : 12:00) - prnewswire.com
RDHL | $0.4278 -3.3% -3.44% 470K
|
Health Technology
|
| O: 122.69%
H: 62.25%
C: 42.33%
talicia fda biopharma grant market
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
Published: 2024-03-04 (Crawled : 13:00) - globenewswire.com
QNRX | $0.66 -0.17% 83K
|
Professional, Scientific, and T...
|
| O: 113.71%
H: 4.39%
C: -51.01%
fda clearance ongoing pharmaceuticals
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer
Published: 2023-01-05 (Crawled : 15:00) - biospace.com/
ABVC | $1.35 29.81% 23.53% 1.1M
|
Wholesale Trade
|
| O: 106.45%
H: 46.09%
C: -16.41%
abv-1519 treatment fda biopharma lung cancer study submission
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Published: 2022-12-29 (Crawled : 14:00) - prnewswire.com
HOTH | $1.19 3.48% 1.2% 110
|
Health Technology
|
| O: 102.05%
H: 40.61%
C: 20.58%
ht-001 treatment fda application therapeutics therapy cancer growth
Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023
Published: 2023-11-13 (Crawled : 13:30) - globenewswire.com
TENX | $3.5 -1.69% 0.84% 11K
|
Health Technology
|
| O: 100.38%
H: 130.23%
C: 98.34%
tnx-103 fda expected treatment clearance hypertension heart therapeutics
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery SystemInnovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges
Published: 2022-06-27 (Crawled : 11:00) - biospace.com/
AFIB | $0.1689 0.78% 0.89% 110K
|
Health Technology
|
| O: 96.88%
H: 14.62%
C: -4.72%
fda system extension commercial
Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ARDS | $0.0635 -1.55% 2.82% 0
|
Health Technology
|
| O: 94.59%
H: 49.86%
C: 10.39%
ar-301 fda agreement study
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
Published: 2022-05-13 (Crawled : 12:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 92.39%
H: 0.0%
C: 0.0%
skinte fda designation granted therapy grant
Virios Therapeutics Announces Initial FDA Feedback on Proposed IMC-1 Phase 3 Program for Treatment of Fibromyalgia
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
VIRI | $0.431 1.24% -0.92% 79K
|
Health Technology
|
| O: 91.91%
H: 20.0%
C: -19.17%
fda fibromyalgia treatment program therapeutics
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
Published: 2023-12-26 (Crawled : 14:00) - prnewswire.com
IINN | $1.86 -2.11% -1.06% 48K
|
Manufacturing
|
| O: 89.08%
H: 10.67%
C: -43.56%
fda blood clearance results submission
ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis
Published: 2021-10-08 (Crawled : 11:56) - ir.chemocentryx.com
CCXI | News | $51.99 -0.04%
|
Health Technology
|
| O: 88.44%
H: 0.0%
C: 0.0%
fda fda approval avacopan approval anca vasculitis neutrophils
Caldolor® Now FDA Approved For Pre-Operative Administration
Published: 2021-11-29 (Crawled : 21:00) - prnewswire.com
CPIX | $1.64 1.23% 0.61% 14
|
Health Technology
|
| O: 87.73%
H: 32.69%
C: 21.79%
fda
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
EAST | $1.0835 16.17% 15.21% 100
|
Commercial Services
BOF | $1.17 6.36% 14.73% 15K
|
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
BNED | $0.2064 2.64% 8.96% 1.4M
|
Retail Trade
HLTH | $0.15 6.38% 7.84% 21K
|
LRN 4 | $58.2 0.17% 7.56% 950K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.